Recro Pharma shares tumble after FDA sends second response letter about pain killer meloxicam
Shares of Recro Pharma Inc (NASDAQ:REPH) dove Monday after the pharmaceutical company received a second complete response letter from the Food and Drug Administration about its new drug application for its intravenous drug meloxicam to treat moderate to severe pain.
The FDA’s comments in the letter note that IV meloxicam’s delayed onset fails to meet prescribers’ expectations for intravenous (IV) drugs. Regulators also have concerns over the use of meloxicam as a monotherapy for acute pain.
In response, Recro shares tumbled 37% to hit $6.05 in morning trade Monday.
The Malvern, Pennsylvania company said it “strongly disagrees” with the FDA’s interpretation and its views on the utility of IV meloxicam to address acute pain.
READ: Oppenheimer says Recro Pharma on track for approval of painkiller as overhang over stock eliminated
“We are extremely disappointed with the receipt of a second CRL from the FDA,” said Gerri Henwood, CEO of Recro Pharma in a statement. “We remain steadfast in our belief that IV meloxicam holds significant potential as a treatment option for moderate to severe pain in multiple clinical settings and remain committed to pursuing a path to regulatory approval.”
Recro will request a meeting with the FDA as it continues to seek the drug’s approval.
It received its first complete response letter in response to meloxicam last May. At the time, regulators said that data suggests the non-opioid pain killer’s analgesic effect fails to meet FDA expectations.
Recro Pharma is a specialty pharmaceutical company that operates via two businesses: an Acute Care hospital product division, and a revenue-generating contract development and manufacturing group in Gainesville, Georgia.
Contact Ellen Kelleher at [email protected]
Story by ProactiveInvestors
Source: https://www.proactiveinvestors.com/companies/news/217152/recro-pharma-shares-tumble-after-fda-sends-second-response-letter-about-pain-killer-meloxicam-217152.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Lion’s Mane Mushroom
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes:
Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.
Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.
Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.
Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.
Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.
| Online: | |
| Visits: | 1,610,550,423 |
| Stories: | 8,171,123 |
Whistler Blowers, Insiders
